Literature DB >> 205179

Watery diarrhea syndrome. Two unusual cases and further evidence that VIP is a humoral mediator.

A M Cooperman, D Desantis, E Winkelman, R Farmer, J Eversman, S Said.   

Abstract

Two unusual cases of the watery diarrhea syndrome are presented. In one patient an adrenal medullary tumor, a pheochromocytoma that produced vasoactive intestinal polypeptide (VIP) was excised with total relief of symptoms. The second patient a 65-year-old man with abrupt onset of massive watery diarrhea that led to acidosis and coma was symptomatically controlled for one year on 10 mg/day of prednisone. Elevated levels of VIP returned to normal after prednisone therapy was started. A benign islet cell tumor not localized by angiography was removed by distal pancreatic resection. Tissue levels of VIP were markedly elevated. VIP is a humoral mediator of the water diarrhea syndrome. Both benign and malignant pancreatic and extrapancreatic tumors may cause the watery diarrhea syndrome. Steroids may cause symptomatic relief of the diarrhea by lowering peptide levels to normal. The term watery diarrhea syndrome may be more accurate than the pancreatic cholera syndrome.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205179      PMCID: PMC1396422          DOI: 10.1097/00000658-197803000-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia.

Authors:  J V VERNER; A B MORRISON
Journal:  Am J Med       Date:  1958-09       Impact factor: 4.965

2.  Isletcell tumour of the pancreas with peptic ulceration, diarrhoea, and hypokalaemia.

Authors:  W M PRIEST; M K ALEXANDER
Journal:  Lancet       Date:  1957-12-07       Impact factor: 79.321

3.  Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.

Authors:  C J Schwartz; D V Kimberg; H E Sheerin; M Field; S I Said
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

4.  Endocrine pancreatic islet disease with diarrhea. Report of a case due to diffuse hyperplasia of nonbeta islet tissue with a review of 54 additional cases.

Authors:  J V Verner; A B Morrison
Journal:  Arch Intern Med       Date:  1974-03

5.  Studies on the potential role of secretin in the islet cell tumor diarrheogenic syndrome.

Authors:  L J Sanzenbacher; H S Mekhjian; D R King; R M Zollinger
Journal:  Ann Surg       Date:  1972-09       Impact factor: 12.969

6.  Vasoactive intestinal peptide and watery-diarrhoea syndrome.

Authors:  S R Bloom; J M Polak; A G Pearse
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

7.  Pancreatic cholera due to production of gastric inhibitory polypeptide.

Authors:  E Elias; J M Polak; S R Bloom; A G Pearse; R B Welbourn; C C Booth; M Kuzio; J C Brown
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

8.  Cholera-like diarrhoea induced by glucagon plus gastrin.

Authors:  G O Barbezat; M I Grossman
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

9.  Identification of the diarrheogenic hormone associated with non-beta islet cell tumors of the pancreas.

Authors:  R M Zollinger; R K Tompkins; J R Amerson; G L Endahl; A R Kraft; F T Moore
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

10.  Prolonged remission of diarrhea due to nonbeta islet cell tumor of the pancreas by radiotherapy.

Authors:  F T Moore; H Nadler; D A Radefeld; R M Zollinger
Journal:  Am J Surg       Date:  1968-06       Impact factor: 2.565

View more
  10 in total

1.  Adrenal ganglioneuroma-pheochromocytoma secreting vasoactive intestinal polypeptide.

Authors:  L N Contreras; D Budd; T S Yen; C Thomas; J B Tyrrell
Journal:  West J Med       Date:  1991-03

2.  Ectopic hormone-secreting pheochromocytoma: a francophone observational study.

Authors:  James Kirkby-Bott; Laurent Brunaud; Muriel Mathonet; Etienne Hamoir; Jean-Louis Kraimps; Christophe Trésallet; Laurence Amar; Alexandre Rault; Jean-Francois Henry; Bruno Carnaille
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

3.  Angiographic diagnosis of a pancreatic islet tumor in a patient with the WDHA syndrome.

Authors:  K Inamoto; F Yoshino; N Nakao; M Kawanaka
Journal:  Gastrointest Radiol       Date:  1980-08-15

4.  Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.

Authors:  S I Said
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

5.  Surgical management of malignant islet cell tumors.

Authors:  C S Grant
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

6.  Immunohistochemical study of pheochromocytomas. An investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, beta-endorphin, and calcitonin in 16 tumors.

Authors:  J Hassoun; G Monges; P Giraud; J F Henry; C Charpin; H Payan; M Toga
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

7.  Watery diarrhea syndrome due to an adrenal pheochromocytoma secreting vasoactive intestinal polypeptide.

Authors:  S G Sackel; J E Manson; S J Harawi; R Burakoff
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

Review 8.  Watery diarrhea, hypokalemia and achlorhydria syndrome due to an adrenal pheochromocytoma.

Authors:  Shin-ichi Ikuta; Chiaki Yasui; Masahiro Kawanaka; Tsukasa Aihara; Hidenori Yoshie; Hidenori Yanagi; Masao Mitsunobu; Ayako Sugihara; Naoki Yamanaka
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

9.  Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).

Authors:  R G Long; M G Bryant; S J Mitchell; T E Adrian; J M Polak; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

10.  A rare case of watery diarrhea, hypokalemia and achlorhydria syndrome caused by pheochromocytoma.

Authors:  Jingjing Jiang; Li Zhang; Zhaodi Wu; Zhilong Ai; Yingyong Hou; Zhiqiang Lu; Xin Gao
Journal:  BMC Cancer       Date:  2014-07-31       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.